Who Owns BMED?
iShares Health Innovation Active ETF — Institutional Ownership & 13F Holdings
$28.43
+0.00 (+0.00%)
Market Cap
$4.5M
Shares Outstanding
151,578
Institutional Holders
3
Total Inst. Value
$322K
% of Float Held
—
QoQ Holder Change
-2
Institutional data as of Q1 2025
New Positions
0
Closed Positions
1
Increased
1
Decreased
2
Institutional Ownership Trend
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $237K | 9,768 |
| 2 | OSAIC HOLDINGS, INC. | $85K | 3,499 |
| 3 | UBS Group AG | $24 | 1 |
Biggest Buyers & Sellers This Quarter
Top Buyers
| Fund | Shares Added | Value |
|---|---|---|
| CITADEL ADVISORS LLC | +1K | $237K |
Top Sellers
| Fund | Shares Removed | Value |
|---|---|---|
| UBS Group AG | -400 | $24 |
| OSAIC HOLDINGS, INC. | -182 | $85K |
Related Stocks
Frequently Asked Questions
How many institutional investors hold BMED?
As of Q1 2025, 3 institutional investors report holding BMED (iShares Health Innovation Active ETF) in their 13F filings.
Which hedge fund owns the most BMED?
The largest institutional holder of BMED is CITADEL ADVISORS LLC with $237K in shares.
Are institutions buying or selling BMED?
This quarter, 0 institutions opened new positions in BMED and 1 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.